On 17 September, the H2020-funded AI-Mind project held its general assembly meeting as a hybrid event (online and in Oslo, Norway). The project kicked off in March 2021 and aims to facilitate a paradigm shift in clinical practice. AI-Mind will create intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment. Ira Haraldsen (Oslo University Hospital, OUS, Norway) coordinator of the AI-Mind project, kicked off the meeting by welcoming more than 60 members from its consortium counting 15 partners, with 40 delegates participating in person.
The meeting divided between morning and afternoon sessions focused on the project’s aim – how to tackle the challenge of dementia prediction with the use of innovative technologies. The event was as well an exceptional occasion to get insights from the AI-Mind advisory board of which members were present at the assembly, including Francesca Sofia, Hernando Ombao, Ole Petter Ottersen, James Rowe, Klas Pettersen, Richard Milne and Andreas Keller. All agreed that the AI-Mind project is an important initiative that can enhance a patient’s diagnostic journey and consequently the quality of life of those affected by mild cognitive impairment or ones who are onset to dementia. The general assembly meeting concluded with parallel breakout sessions dedicated to the various work packages. Ira then drew the meeting to a close, thanking all the participants for their active contribution to the meeting. Alzheimer Europe (AE) is involved in the ethics, Patient and Public Involvement (PPI) and communication activities of the project. Angela, Cindy, Dianne, Ana and Chris took part in the meeting.
The AI-Mind project is funded by Horizon 2020, for a duration of 5 years. It will conclude in February 2026. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 964220.
